passages.id: 26
passages.type: sentence
passages.text: We investigated whether 5 to 20mg per week oral methotrexate could slow down disease progression in 44 patients with inclusion body myositis in a randomized double-blind placebo-controlled study over 48 weeks .
entities.id: 27
entities.type: intervention
entities.text: methotrexate
entities.id: 28
entities.type: outcome
entities.text: disease progression
entities.id: 29
entities.type: participant
entities.text: 44 patients with inclusion body myositis